A new CSP position was established today on Novartis (NVS). All prices include IB commissions.
This is the second position on NVS.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Challenger |
| Years of Consecutive Dividend Increases | 9 |
| Years of Positive Free Cash Flow (last 10 years) | 10 |
| Ratio of P/E at Cost / 5yr Average P/E | 0.76 |
| Discount to Morningstar's Fair Value Estimate | 26.06% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 2/8/2011 | NVS | CSP Margin Used | CSP 100 NVS @ 52.50 | ($5,250.00) | ||
| 2/8/2011 | NVS | Initial Put Option | STO 1 Apr 52.50 Put @ 1.29 | $129.24 |
Position Summary
| Cost Basis | ($5,250.00) |
| Income Generated | $129.24 |
| Percent Income Generated | 2.46% |
| Annualized Income Generated | 13.61% |
| Net Profit If Assigned | $129.24 |
| Percent Return If Assigned | 2.46% |
| Annualized Return If Assigned | 13.61% |
| Days Held to Expiration | 66 days |
